Dinesh Parmar
Medical Oncology · Gadsden, ALNPI 1821084534
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.1% of the total across 91 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 13.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $620 and has fallen 97.6% since, to $15 in 2024. That places this record below the midpoint for medical oncology clinicians in AL, where the typical reported total is $5,924.
Across 91 payments — averaging $19.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$228
- Sanofi$166
- Pfizer$128
- Sobi, Inc$119
- E.r. Squibb & Sons, L.L.C.$90
- AstraZeneca$84
- plus $918 from 26 others
What the payments were for
- Food & beverage$1,70198%
- Education$332%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 13 | $228 |
| Sanofi | 3 | $166 |
| Pfizer | 10 | $128 |
| Sobi, Inc | 3 | $119 |
| E.r. Squibb & Sons, L.L.C. | 5 | $90 |
| AstraZeneca | 4 | $84 |
| Partner Therapeutics, Inc. | 4 | $79 |
| Exelixis Inc. | 6 | $77 |
| Merck | 4 | $75 |
| Daiichi Sankyo Inc. | 3 | $62 |
| Seagen Inc. | 4 | $57 |
| Tesaro, Inc. | 2 | $53 |
| Incyte Corporation | 3 | $49 |
| Coherus Oncology, Inc. | 3 | $48 |
| Jazz Pharmaceuticals Inc. | 2 | $42 |
| Dova Pharmaceuticals | 2 | $40 |
| Pharmacyclics LLC, An Abbvie Company | 2 | $38 |
| Bristol Myers Squibb | 2 | $36 |
| Lilly USA, LLC | 2 | $35 |
| Bayer | 2 | $34 |
| Janssen Scientific Affairs, LLC | 1 | $31 |
| Eisai Inc. | 1 | $22 |
| Deciphera Pharmaceuticals Inc. | 1 | $21 |
| Karyopharm Therapeutics Inc. | 1 | $17 |
| Myovant Sciences Inc. | 1 | $16 |
| Global Blood Therapeutics, Inc. | 1 | $16 |
| Puma Biotechnology, Inc. | 1 | $15 |
| AVEO Pharmaceuticals, Inc. | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
| Amgen | 1 | $13 |
| EMD Serono, Inc. | 1 | $12 |
| Secura Bio, Inc. | 1 | $4 |
How this compares
$1,734 in reported general payments places this provider in the 20th percentile of 30 medical oncology providers in Alabama.
Other medical oncology in Gadsden
- Elquis CastilloGadsden$3K
- Joelle HamiltonHomewood$361K
- Syed Abbas AliJasper$51K
- Pranitha ProdduturvarMobile$33K
- Johnny NacillaCullman$23K
- Michael GarciaJasper$23K
- John WaplesHuntsville$19K
- Susan BostickTuscaloosa$17K
- Brittany CaseDaphne$17K
- Charles LattuadaAnniston$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.